| « | » |
There may be more answers discussed within the BioStats chapter, but they were hard to find bc they are embedded in the notes. If you post the page numbers, I can try to find more. Hope this helps.
pg 149 Descriptive Stats Example
Sample Data Set Mean = 60.8 Median = 61 Mode = 65
Std Deviation = no answer given, will not be expected to calculate
Range can be reported as either 87 - 46 or 41
pg 154-155 Rosuvastatin vs Simvastatin
Which is the most appropriate stat test to determine baseline differences in
A) Sex: Chi Squared
B) LDL: Independent t test aka 2 sample
C) % smoker vs. non-smoker: Chi Squared
Which is the most appropriate test to determine:
A) Effect of rosuvastatin on LDL: Wilcoxen Signed Rank Sum
Very confusing to the group. The key here (as explained) is that the samples are Paired. The measurements in the rosuvastatin group at baseline and compared against the same patients again at the 3 month mark.
B) The primary endpoint: 2 Sample t test
pg 158 Regression example
8c. i. Parametric, continuous values
ii. 31% of variability in Factor Xa conc. is explained by the Enox dose
iii. For 2mg ~ 0.5 U/mL; Cannot predict 3.75 because it is outside range of the experiment
Attachments:
Answers BioStats chapter.doc (23 KB)